Inventor · disambiguated record
Masamichi Sugimoto
Also filed as: SUGIMOTO MASAMICHI
8 granted patents·9 pending applications·257 citations·filing 2001–2022
89Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD10ITO HIROAKI2KATAOKA HIROAKI1LAZAR GREGORY A1LAZAR GREGORY ALAN1
Top patents by PatentIndex Score
17 records- 0197US7320792B2Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonistCHUGAI PHARMACEUTICAL CO LTD·Filed 2001·Granted Jan 22, 2008·147 cites·3 claims
- 0292US9102739B2Anti-glypican-3 antibodyLAZAR GREGORY ALAN·Filed 2006·Granted Aug 11, 2015·17 cites·24 claims
- 0392US7867734B2Anti-glypican 3 antibody having modified sugar chainCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted Jan 11, 2011·23 cites·8 claims
- 0491US7871613B2Adjuvant therapy with the use of anti-glypican 3 antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2005·Granted Jan 18, 2011·28 cites·20 claims
- 0590US8597644B2Method for treating psoriasis by administering an antibody to interleukin-6 receptorITO HIROAKI·Filed 2007·Granted Dec 3, 2013·16 cites·6 claims
- 0690US8562990B2Method of treating psoriatic arthritis with an IL-6 receptor antibodyITO HIROAKI·Filed 2011·Granted Oct 22, 2013·16 cites·16 claims
- 0780US8663929B2Method for detection of liver cancer cell using anti-glypican-3 antibodyKATAOKA HIROAKI·Filed 2009·Granted Mar 4, 2014·9 cites·12 claims
- 0875US10118959B2Anti-glypican-3 antibodyXENCOR INC·Filed 2014·Granted Nov 6, 2018·1 cites·10 claims
- 0969US2023091221A1Pharmaceutical compositionCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1054US2007087005A1Anti-glypican-3 antibodyLAZAR GREGORY A·Filed 2005·Application pending·0 cites
- 1154US2021198364A1Pharmaceutical compositionCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1252US2023146730A1Biomarkers for predicting the response to checkpoint inhibitorsCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1351US2009061485A1Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is InhibitedCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Application pending·0 cites
- 1450US2011104157A1Liver cancer drugCHUGAI PHARMACEUTICAL CO LTD·Filed 2009·Application pending·0 cites
- 1546US2011033452A1Anti-Glypican 3 Antibody Having Modified Sugar ChainCHUGAI PHARMACEUTICAL CO LTD·Filed 2010·Application pending·0 cites
- 1646US2008166756A1Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is InhibitedTSUCHIYA MASAYUKI·Filed 2005·Application pending·0 cites
- 1745US2007142627A1Sugar-chain-altered anti-hm1.24 antibodyCHUGAI PHARMACEUTICAL CO LTD·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Masamichi Sugimoto files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →